International CNN
Eli Lilly's New GLP-1 Pill Aids Significant Weight Loss in Obese Patients, Trial Finds
Eli Lilly's once-daily oral GLP-1 pill helped participants in a Phase 3 trial lower their weight by an average of 12% after 72 weeks.
Eli Lilly's experimental GLP-1 pill has helped people with obesity lose weight by an average of 12% in a 72-week Phase 3 trial, marking a significant milestone for the once-daily oral treatment in treating weight loss.
Brief written with AI from reporting by CNN. All rights to the original story belong to the publisher.
Read the original on CNN
Share